Effect of Baduanjin Sequential Therapy on the Quality of Life and Cardiac Function in Patients with AMI After PCI: A Randomized Controlled Trial.
Ming-Gui ChenXuefei LiangLili KongJingjing WangFangfang WangXiyan HuJianzhuo HeRui-Xiang ZengShuai MaoLiheng GuoMin-Zhou ZhangXiaoxuan ZhangPublished in: Evidence-based complementary and alternative medicine : eCAM (2020)
The BST appears to improve the quality of life in patients with AMI after PCI, with additional benefits of lowered abdominal circumference and BMI and improved level of cardiac function. This trial is registered with NCT02693795.
Keyphrases
- acute myocardial infarction
- body mass index
- percutaneous coronary intervention
- coronary artery disease
- left ventricular
- st segment elevation myocardial infarction
- acute coronary syndrome
- antiplatelet therapy
- study protocol
- st elevation myocardial infarction
- phase iii
- clinical trial
- phase ii
- weight gain
- coronary artery bypass grafting
- atrial fibrillation
- randomized controlled trial
- heart failure
- stem cells
- open label
- replacement therapy